The warm sunshine of spring is a welcome change from the cold and brutal winds of winter in the Upper Midwest. However, with ...

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

Compr Ophthalmol Update. 2007;8(1):1-14. The micronodular (. 15%) variant shows smaller tumor nodules (< 0.15 mm by definition) (Figure 1C) and has an increased tendency for subclinical extension.

The case of a 83-year-old patient with a pomade crust on the scalp mimicking recurrent basal cell carcinoma is reported. Pomade crusts can develop after intense application of certain skin care ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer ...

The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90). The Company to Expand the Study into Additional Trial Sites in Europe Philadelphia ...

To overcome this hurdle, the researchers designed a multifunctional nanoplatform capable of reshaping the tumor microenvironment and enhancing the body's natural immune defense against cancer.